ResMed Aktie
WKN DE: 895878 / ISIN: US7611521078
24.01.2024 22:45:15
|
Resmed Inc Q2 Profit Decreases, but beats estimates
(RTTNews) - Resmed Inc (RMD) announced earnings for second quarter that decreased from last year but beat the Street estimates.
The company's earnings totaled $208.80 million, or $1.42 per share. This compares with $224.91 million, or $1.53 per share, in last year's second quarter.
Excluding items, Resmed Inc reported adjusted earnings of $277.35 million or $1.88 per share for the period.
Analysts on average had expected the company to earn $1.79 per share, according to figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.
The company's revenue for the quarter rose 12.6% to $1.16 billion from $1.03 billion last year.
Resmed Inc earnings at a glance (GAAP) :
-Earnings (Q2): $208.80 Mln. vs. $224.91 Mln. last year. -EPS (Q2): $1.42 vs. $1.53 last year. -Analyst Estimates: $1.79 -Revenue (Q2): $1.16 Bln vs. $1.03 Bln last year.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu ResMed Inc.mehr Nachrichten
Analysen zu ResMed Inc.mehr Analysen
Aktien in diesem Artikel
ResMed Inc. | 219,20 | 1,34% |
|